ArticleInternational journal of colorectal disease2018

Anti-angiogenic agents in second-line treatment for metastatic colorectal cancer: the optimization of pharmacological costs.

Jacopo Giuliani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.